0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Gouty Arthritis (Gout) - Epidemiology Forecast to 2028
Published Date: April 2019
|
Report Code: DELV-Epid-453
Home | Market Reports | Health | Health Conditions | Arthritis
Gouty Arthritis Epidemiology Forecast to 2028

Gouty Arthritis (Gout) - Epidemiology Forecast to 2028

Code: DELV-Epid-453
Report
April 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

DelveInsight's "Gouty Arthritis (Gout) - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Gouty Arthritis (Gout) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Gouty Arthritis (Gout) Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Gouty Arthritis (Gout) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Gouty Arthritis (Gout) outlook. It also includes the explanation of changing trends of epidemiology outlining the Gouty Arthritis (Gout) scenario.

Gouty Arthritis (Gout) Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Gouty Arthritis (Gout) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Gouty Arthritis (Gout) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Gouty Arthritis (Gout) Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Gouty Arthritis (Gout)

Key assessments
• Patient Segmentation in Gouty Arthritis (Gout)
• Gouty Arthritis (Gout) Risk & Burden
• Factors driving growth in a specific Gouty Arthritis (Gout) patient population

1. Report Introduction
2. Gouty Arthritis (Gout) Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Gouty Arthritis (Gout) in 2016
2.2. Patient Share Distribution of Gouty Arthritis (Gout) in 2028
3. Disease Background and Overview: Gouty Arthritis (Gout)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Gouty Arthritis (Gout) in 7MM
4.3. Total Prevalent/ Incident Patient Population of Gouty Arthritis (Gout) in 7MM – By Countries
5. Epidemiology of Gouty Arthritis (Gout) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Gouty Arthritis (Gout)
5.1.3. Sub-Type Specific cases of the Gouty Arthritis (Gout) *
5.1.4. Sex- Specific Cases of the Gouty Arthritis (Gout) *
5.1.5. Diagnosed Cases of the Gouty Arthritis (Gout)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Gouty Arthritis (Gout)
5.4.3. Sub-Type Specific cases of the Gouty Arthritis (Gout) *
5.4.4. Sex- Specific Cases of the Gouty Arthritis (Gout) *
5.4.5. Diagnosed Cases of the Gouty Arthritis (Gout)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Gouty Arthritis (Gout)
5.5.3. Sub-Type Specific cases of the Gouty Arthritis (Gout) *
5.5.4. Sex- Specific Cases of the Gouty Arthritis (Gout) *
5.5.5. Diagnosed Cases of the Gouty Arthritis (Gout)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Gouty Arthritis (Gout)
5.6.3. Sub-Type Specific cases of the Gouty Arthritis (Gout) *
5.6.4. Sex- Specific Cases of the Gouty Arthritis (Gout) *
5.6.5. Diagnosed Cases of the Gouty Arthritis (Gout)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Gouty Arthritis (Gout)
5.7.3. Sub-Type Specific cases of the Gouty Arthritis (Gout) *
5.7.4. Sex- Specific Cases of the Gouty Arthritis (Gout) *
5.7.5. Diagnosed Cases of the Gouty Arthritis (Gout)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Gouty Arthritis (Gout)
5.8.3. Sub-Type Specific cases of the Gouty Arthritis (Gout) *
5.8.4. Sex- Specific Cases of the Gouty Arthritis (Gout) *
5.8.5. Diagnosed Cases of the Gouty Arthritis (Gout)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Gouty Arthritis (Gout)
5.9.3. Sub-Type Specific cases of the Gouty Arthritis (Gout) *
5.9.4. Sex- Specific Cases of the Gouty Arthritis (Gout) *
5.9.5. Diagnosed Cases of the Gouty Arthritis (Gout)
6. Unmet Needs of the Gouty Arthritis (Gout)
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Tables :

Table 1: Total Prevalent/Incident Cases of the Gouty Arthritis (Gout) in 7MM
Table 2: Total Prevalent/Incident Cases of the Gouty Arthritis (Gout) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Gouty Arthritis (Gout) in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Gouty Arthritis (Gout) in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Gouty Arthritis (Gout) in United States (2016-2028)*
Table 6: Diagnosed Cases of the Gouty Arthritis (Gout) in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Gouty Arthritis (Gout) in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Gouty Arthritis (Gout) in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Gouty Arthritis (Gout) in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Gouty Arthritis (Gout) in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Gouty Arthritis (Gout) in France (2016-2028)
Table 12: Sub-Type Specific cases of the Gouty Arthritis (Gout) in France (2016-2028) *
Table 13: Sex- Specific Cases of the Gouty Arthritis (Gout) in France (2016-2028) *
Table 14: Diagnosed Cases of the Gouty Arthritis (Gout) in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Gouty Arthritis (Gout) in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Gouty Arthritis (Gout) in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Gouty Arthritis (Gout) in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Gouty Arthritis (Gout) in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Gouty Arthritis (Gout) in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Gouty Arthritis (Gout) in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Gouty Arthritis (Gout) in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Gouty Arthritis (Gout) in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Gouty Arthritis (Gout) in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Gouty Arthritis (Gout) in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Gouty Arthritis (Gout) in UK (2016-2028) *
Table 26: Diagnosed Cases of the Gouty Arthritis (Gout) in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Gouty Arthritis (Gout) in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Gouty Arthritis (Gout) in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Gouty Arthritis (Gout) in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Gouty Arthritis (Gout) in Japan (2016-2028)


LIst of Figures :

Figure 1: Total Prevalent/Incident Cases of the Gouty Arthritis (Gout) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Gouty Arthritis (Gout) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Gouty Arthritis (Gout) in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Gouty Arthritis (Gout) in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Gouty Arthritis (Gout) in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Gouty Arthritis (Gout) in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Gouty Arthritis (Gout) in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Gouty Arthritis (Gout) in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Gouty Arthritis (Gout) in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Gouty Arthritis (Gout) in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Gouty Arthritis (Gout) in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Gouty Arthritis (Gout) in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Gouty Arthritis (Gout) in France (2016-2028) *
Figure 14: Diagnosed Cases of the Gouty Arthritis (Gout) in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Gouty Arthritis (Gout) in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Gouty Arthritis (Gout) in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Gouty Arthritis (Gout) in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Gouty Arthritis (Gout) in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Gouty Arthritis (Gout) in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Gouty Arthritis (Gout) in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Gouty Arthritis (Gout) in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Gouty Arthritis (Gout) in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Gouty Arthritis (Gout) in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Gouty Arthritis (Gout) in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Gouty Arthritis (Gout) in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Gouty Arthritis (Gout) in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Gouty Arthritis (Gout) in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Gouty Arthritis (Gout) in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Gouty Arthritis (Gout) in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Gouty Arthritis (Gout) in Japan (2016-2028)

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3250
This license allows only one user to access the PDF.

Electronic (PDF)
$6500
This license allows all the users of an enterprise residing in one location to access the PDF

Electronic (PDF)
$9750
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Leap India

RELATED REPORTS

Global and United States Rheumatoid Arthritis and Lupus Treatments Market Report Forecast 2022 2028
Global and United States Rheumatoid Arthritis and Lupus Treatments Market Report & Forecast 2022-2028

Rheumatoid arthritis and lupus belong to a number of autoimmune diseases affecting the musculoskeletal system multisystemic tissue and connective tissues.Market Analysis and Insights Global and United States Rheumatoid Arthritis and Lupus Treatments MarketThis report focuses on global and United States Rheumatoid Arthritis and Lupus Treatments market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Rheumatoid Arthritis and Lupus Treatments market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-24H10250
Tue Apr 05 00:00:00 UTC 2022

Add to Cart

Global and United States Prescription Arthritis Medications Market Report Forecast 2022 2028
Global and United States Prescription Arthritis Medications Market Report & Forecast 2022-2028

Arthritis medicines are generally very effective in helping people with arthritis to manage joint pain and other symptoms.Market Analysis and Insights Global and United States Prescription Arthritis Medications MarketThis report focuses on global and United States Prescription Arthritis Medications market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Prescription Arthritis Medications market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-39T10333
Tue Apr 05 00:00:00 UTC 2022

Add to Cart

Global Rheumatoid Arthritis RA Medications Market Research Report 2022
Global Rheumatoid Arthritis (RA) Medications Market Research Report 2022

Rheumatoid arthritis medications are medications developed for different therapeutic targets of this type of disease.Due to the COVID19 pandemic the global Rheumatoid Arthritis RA Medications market size is estimated to be worth US million in 2021 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the forecast period 20222028.

120 Pages
Type: Report
Code: QYRE-Auto-10C10123
Fri Mar 04 00:00:00 UTC 2022

Add to Cart

Global Rheumatoid Arthritis Devices Market Insights Forecast to 2028
Global Rheumatoid Arthritis Devices Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-23A7794
Thu Mar 03 00:00:00 UTC 2022

Add to Cart